The MedicX Fund Limited Publication of Circular - Scrip Dividend Scheme (8131O)
24 August 2017 - 12:04AM
UK Regulatory
TIDMMXF
RNS Number : 8131O
The MedicX Fund Limited
23 August 2017
For immediate release
23 August 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Publication of Circular to Shareholders - Scrip Dividend
Scheme
On 28 July 2017, the Board of MedicX Fund Limited (the
"Company") announced -
(a) that a quarterly dividend of 1.5p per ordinary share
("Ordinary Share") had been approved in respect of the period 1
April 2017 to 31 June 2017, payable on 28 September 2017 to
Shareholders on the register as at close of business on 18 August
2017 (the "September 2017 Dividend"); and (b) that Shareholders
would be offered the opportunity to take up new Ordinary Shares
("Scrip Shares") instead of cash in respect of that dividend,
subject to certain terms and conditions, by participating in the
Scrip Dividend Scheme (the "Scheme").
Accordingly, the Board is now pleased to offer qualifying
Shareholders the opportunity to receive the September 2017 Dividend
in Scrip Shares (the "Scrip Dividend Alternative") instead of in
cash.
The Company posted yesterday, to any Shareholders new to the
Company since 20 May 2017, a letter from the Chairman and a scheme
document setting out the detailed terms and conditions of the
Scheme (together the "Circular"). The Circular provides details of
the Scrip Dividend Alternative and explains how Shareholders may
elect to receive the Scrip Dividend Alternative instead of cash
dividends. A mandate form for certificated Shareholders to elect
for the Scrip Dividend Alternative (the "Mandate Form") is also
included. Copies of the Circular and an example of the Mandate Form
are available on the Company's website
(http://www.medicxfund.com/scrip). Any existing shareholders at 18
August 2017 who require a new mandate form are asked to contact
Capita Asset Services on 0871 664 0300*.
Scrip dividends are attractive to many shareholders because they
enable them to increase their holding in the Company in a simple
manner without incurring any dealing costs or stamp duty. At the
same time, the Company will retain more cash in its business which
would otherwise be paid as a dividend. There may be further
advantages to receiving the dividend in this form and shareholders
are encouraged to review the details of the Scheme and the
associated documents, which may be found on the Company website, or
alternatively may be viewed through the National Storage Mechanism
(www.morningstar.co.uk/uk/nsm).
The price at which the September 2017 Dividend will be converted
into Scrip Shares (the "Scrip Calculation Price") will be announced
to the London Stock Exchange on 25 August 2017. This announcement
(together with details of the Scheme) will also appear on the
Company's website www.medicxfund.com. The Scrip Calculation Price
is the average of the closing middle market quotations of an
Ordinary Share, derived from the London Stock Exchange Daily
Official List, for the five consecutive business days commencing on
the Ex-dividend Date.
If qualifying Shareholders wish to elect to participate in the
Scrip Dividend Alternative in relation to the September 2017
Dividend their Mandate Form (or relevant CREST election) must be
received by Capita Asset Services by no later than 5.00 p.m. on 7
September 2017 (the "Delivery Deadline"). Shareholders should refer
to the Circular for the full terms and conditions of the Scheme and
the election procedure for certificated and uncertificated
Shareholders.
Forms remain valid for all Relevant Dividends where a Scrip
Dividend Alternative is offered, until cancelled.
A copy of the Circular has been submitted to the Financial
Conduct Authority and is available for inspection through the
National Storage Mechanism (www.morningstar.co.uk/uk/nsm).
*Calls made to this number are charged at 12 pence per minute
plus network charges. Lines are open 8.30 a.m. to 5.30 p.m. (London
time) Monday to Friday (except Bank Holidays).
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the
"Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 156 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25
This information is provided by RNS
The company news service from the London Stock Exchange
END
CIRBSGDIBGDBGRX
(END) Dow Jones Newswires
August 23, 2017 10:04 ET (14:04 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024